Bortezomib 72603-0270

Product NDC

72603-0270

Manufacturer: Northstar Rxllc
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: November 1, 2024
Listing Expires: December 31, 2026
Application: ANDA202963

Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bortezomib	3.5 mg/1

Drug Class

Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Packaging Options(1)

72603-0270-01

1 VIAL, SINGLE-DOSE in 1 CARTON (72603-270-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

View →